nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Multicenter, Open-Label Phase II Study of Metformin With Erlotinib in Second-Line Therapy of Stage IV Non–Small-Cell Lung Cancer Patients: Treatment Rationale and Protocol Dynamics of the METAL Trial
|
Fasano, Morena |
|
2015 |
16 |
1 |
p. 57-59 3 p. |
artikel |
2 |
Chemoprevention and Screening for Lung Cancer: Changing Our Focus to Former Smokers
|
Clamon, Gerald |
|
2015 |
16 |
1 |
p. 1-5 5 p. |
artikel |
3 |
Clinical Likelihood of Sporadic Primary EGFR T790M Mutation in EGFR-Mutant Lung Cancer
|
Lee, Youngjoo |
|
2015 |
16 |
1 |
p. 46-50 5 p. |
artikel |
4 |
Concurrent Chemoradiotherapy for Patients With Postoperative Recurrence of Surgically Resected Non–Small-Cell Lung Cancer
|
Takenaka, Tomoyoshi |
|
2015 |
16 |
1 |
p. 51-56 6 p. |
artikel |
5 |
Editorial Board
|
|
|
2015 |
16 |
1 |
p. A6- 1 p. |
artikel |
6 |
Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non–Small-Cell Lung Cancer
|
Chu, Michael P. |
|
2015 |
16 |
1 |
p. 33-39 7 p. |
artikel |
7 |
Italian Multicenter Phase III Randomized Study of Cisplatin–Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM Trial
|
Tiseo, Marcello |
|
2015 |
16 |
1 |
p. 67-70 4 p. |
artikel |
8 |
Long-Term Lung Cancer Survivors Have Permanently Decreased Quality of Life After Surgery
|
Rauma, Ville |
|
2015 |
16 |
1 |
p. 40-45 6 p. |
artikel |
9 |
Metachronous and Synchronous Primary Lung Cancers: Diagnostic Aspects, Surgical Treatment, and Prognosis
|
Loukeri, Angeliki A. |
|
2015 |
16 |
1 |
p. 15-23 9 p. |
artikel |
10 |
Multimodality Treatment With Surgery for Locally Advanced Non–Small-Cell Lung Cancer With N2 Disease: A Review Article
|
Toyokawa, Gouji |
|
2015 |
16 |
1 |
p. 6-14 9 p. |
artikel |
11 |
Outcomes by Tumor Histology and KRAS Mutation Status After Lung Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer
|
Mak, Raymond H. |
|
2015 |
16 |
1 |
p. 24-32 9 p. |
artikel |
12 |
Rationale and Study Design of the IRENE-Trial (NVALT-16): A Phase II Trial to Evaluate Iressa Rechallenge in Advanced NSCLC Patients With an Activating EGFR Mutation Who Responded to an EGFR-TKI Used As First-Line or Previous Treatment
|
Kuiper, Justine L. |
|
2015 |
16 |
1 |
p. 60-66 7 p. |
artikel |
13 |
Table of Contents
|
|
|
2015 |
16 |
1 |
p. A8-A9 nvt p. |
artikel |